These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27988864)

  • 1. The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.
    Tesei A; Crippa A; Ceccarelli SB; Mauri M; Molteni M; Agostoni C; Nobile M
    Eur Child Adolesc Psychiatry; 2017 Sep; 26(9):1011-1030. PubMed ID: 27988864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
    Parletta N; Niyonsenga T; Duff J
    PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD.
    Agostoni C; Nobile M; Ciappolino V; Delvecchio G; Tesei A; Turolo S; Crippa A; Mazzocchi A; Altamura CA; Brambilla P
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
    Wu Q; Zhou T; Ma L; Yuan D; Peng Y
    Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    J Atten Disord; 2015 Nov; 19(11):954-64. PubMed ID: 24214970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.
    Kidd PM
    Altern Med Rev; 2007 Sep; 12(3):207-27. PubMed ID: 18072818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.
    Checa-Ros A; Haro-García A; Seiquer I; Molina-Carballo A; Uberos-Fernández J; Muñoz-Hoyos A
    Minerva Pediatr; 2019 Aug; 71(4):313-325. PubMed ID: 30419741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.
    Matsudaira T; Gow RV; Kelly J; Murphy C; Potts L; Sumich A; Ghebremeskel K; Crawford MA; Taylor E
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):775-82. PubMed ID: 26682998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder.
    Gow RV; Matsudaira T; Taylor E; Rubia K; Crawford M; Ghebremeskel K; Ibrahimovic A; Vallée-Tourangeau F; Williams LM; Sumich A
    Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):151-6. PubMed ID: 19230637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.
    Sorgi PJ; Hallowell EM; Hutchins HL; Sears B
    Nutr J; 2007 Jul; 6():16. PubMed ID: 17629918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
    Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
    Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.
    Innes JK; Calder PC
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29425187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.
    McNamara RK; Jandacek R; Tso P; Blom TJ; Welge JA; Strawn JR; Adler CM; Strakowski SM; DelBello MP
    Early Interv Psychiatry; 2016 Jun; 10(3):203-11. PubMed ID: 26486098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
    Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
    Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
    [No Abstract]   [Full Text] [Related]  

  • 20. Supplementation of docosahexaenoic acid (DHA) / Eicosapentaenoic acid (EPA) in a ratio of 1/1.3 during the last trimester of pregnancy results in EPA accumulation in cord blood.
    Büyükuslu N; Ovalı S; Altuntaş ŞL; Batırel S; Yiğit P; Garipağaoğlu M
    Prostaglandins Leukot Essent Fatty Acids; 2017 Oct; 125():32-36. PubMed ID: 28987719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.